Pfizer tests experimental drug in healthy people – no disease involved
NCT ID NCT06659250
First seen Nov 01, 2025 · Last updated Jun 16, 2026 · Updated 34 times
Summary
This early-stage study tested the safety and how the body handles different doses of an experimental drug called PF-06414300. 63 healthy adults aged 18-65 received either the drug or a placebo. The goal was to measure side effects and drug levels in the blood, not to treat any illness.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY PARTICIPANTS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Pfizer Clinical Research Unit - New Haven
New Haven, Connecticut, 06511, United States
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.